All News

The FDA has approved the use of ibrutinib (Imbruvica®, AbbVie) in combination with obinutuzumab (Gazyva®) for adult patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

A new web-based application aims to provide an early and accurate diagnosis of pediatric epilepsy.

Torrent Pharmaceuticals Limited is voluntarily recalling 16 lots of Losartan potassium tablets USP and Losartan potassium and hydrochlorothiazide tablets, USP.

Patients who have type 1 diabetes spent a lot more to treat themselves in 2016 than in 2012.

A pilot study has found that a video game designed to treat autism spectrum disorder and co-occurring attention/deficit-hyperactivity disorder (ADHD) is acceptable to kids and parents, and feasible.

Three flu-associated pediatric deaths were reported for the week ended January 12, 2019, according to the CDC.

United States citizens are increasingly traveling to international destinations, with Americans making 38 million visits abroad in 2017, and pharmacists are well-placed to assist patients with their travel health needs.

Officials with the FDA today approved the first generic version of vigabatrin 500-mg tablets, which is also sold under the brand name Sabril, a medication used to treat complex partial seizures.

Rep. Elijah E. Cummings, D-Maryland, who is the Chairman of the Committee on Oversight and Reform announced this week that he has sent letters to 12 drug companies.

Measles outbreaks are on the rise globally, and it is considered a public health crisis.

The FDA has approved Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) use to include repeat vaccination to help protect against tetanus, diphtheria and pertussis.

Between 6 and 7 million people have been sick with influenza so far during the 2018-2019 season, according to data released on Jan. 11, 2019 from the CDC.

All evolocumab (Repatha, Amgen) device options, including the Pre-Filled Syringe and Pushtronex® are now available at a lower list price of $5,850.

An overall 27% drop in the cancer mortality rate translates into 2.6 million fewer deaths from cancer in the United States between the years 1991 and 2016.

The FDA has approved marketing of Lupin Pharmaceuticals’ Lurasidone Hydrochloride Tablets

Lupin Pharmaceuticals, Inc. has voluntarily recalled 42 of lots of Ceftriaxone for Injection, USP products at the hospital/physician level.

A mobile medical application for adults with opioid use disorder (OUD) that aims to increase patient retention for adults who are in outpatient treatment programs is now available by prescription.

A recall of Torrent Pharmaceuticals Limited’s Losartan Potassium Tablets USP has been expanded to include 8 additional lots.

Updated seasonal influenza guidelines from the Infectious Diseases Society of America (IDSA) provide new recommendations for testing and treating patients.

Healthcare workers face a potential silent killer every day that is so common it is routinely overlooked and ignored: accidental needlesticks.

Officials with the US FDA have approved a vaccine for use in children younger than age 5 that is indicated for immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Vaxelisâ„¢).

More than 702,000 Americans died from drug overdoses from 1999 to 2017–about 10% of them in 2017 alone, according to findings from an in-depth CDC analysis of the latest available drug overdose death data from the National Center for Health Statistics.

Women between the ages of 30 and 39 who have at least 1 of 3 breast cancer risk factors may benefit from starting their annual mammography screening at age 30

Officials with Neos Therapeutics, Inc., have announced that they have entered into a confidential settlement and licensing agreement with Teva Pharmaceuticals USA

The FDA has approved calaspargase pegol-mknl (Asparlas, Servier Pharmaceuticals) as a component of a multi-agent chemotherapeutic regimen for acute lymphoblastic leukemia (ALL) in patients aged 1 month to 21 years.

Don’t let a busy holiday season distract you from managing your health and staying safe

Officials with the FDA have approved romiplostim (NPLATE, Amgen) for the treatment of immune thrombocytopenia (ITP) in pediatric patients aged 1 year and older.

Fentanyl topped the list of the the 10 most frequently mentioned drugs cited as in connection with drug overdoses, according to a new report from the CDC.

In the 1970s, investigators discovered that Eskimos, particularly Greenland Inuit, and other populations, such as the Japanese, had very low rates of myocardial infarction and other coronary events, despite consuming large amounts of fat derived from fish.

The FDA has approved Mayne Pharma Group Limited’s New Drug Application for SUBA-itraconazole (Tolsura) 65mg capsules.